Sparano JA - Search Results

1

Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034.

Tan CRC, Barta SK, Lee J, Rudek MA, Sparano JA, Noy A. Tan CRC, et al. Among authors: sparano ja. Leuk Lymphoma. 2018 Aug;59(8):1851-1860. doi: 10.1080/10428194.2017.1403597. Epub 2017 Nov 21. Leuk Lymphoma. 2018. PMID: 29160731 Free PMC article.

2

Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.

Sparano JA, Wiernik PH, Strack M, Leaf A, Becker NH, Sarta C, Carney D, Elkind R, Shah M, Valentine ES, et al. Sparano JA, et al. Leuk Lymphoma. 1994 Jul;14(3-4):263-71. doi: 10.3109/10428199409049677. Leuk Lymphoma. 1994. PMID: 7950915 Clinical Trial.

3

Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancy.

Sparano JA, Sarta C. Sparano JA, et al. Curr Opin Oncol. 1996 Sep;8(5):392-9. doi: 10.1097/00001622-199609000-00010. Curr Opin Oncol. 1996. PMID: 8914806 Review.

4

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH. Sparano JA, et al. J Natl Cancer Inst. 1997 Feb 19;89(4):301-7. doi: 10.1093/jnci/89.4.301. J Natl Cancer Inst. 1997. PMID: 9048834

5

Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma.

Sparano JA, Wiernik PH, Hu X, Sarta C, Henry DH, Ratech H. Sparano JA, et al. Med Oncol. 1998 Apr;15(1):50-7. doi: 10.1007/BF02787345. Med Oncol. 1998. PMID: 9643531 Clinical Trial.

6

Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center.

Sparano JA, Anand K, Desai J, Mitnick RJ, Kalkut GE, Hanau LH. Sparano JA, et al. J Acquir Immune Defic Syndr. 1999 Aug 1;21 Suppl 1:S18-22. J Acquir Immune Defic Syndr. 1999. PMID: 10430213

7

Clinical aspects and management of AIDS-related lymphoma.

Sparano JA. Sparano JA. Eur J Cancer. 2001 Jul;37(10):1296-305. doi: 10.1016/s0959-8049(01)00111-3. Eur J Cancer. 2001. PMID: 11423261 Review.

8

Human immunodeficiency virus associated lymphoma.

Sparano JA. Sparano JA. Curr Opin Oncol. 2003 Sep;15(5):372-8. doi: 10.1097/00001622-200309000-00005. Curr Opin Oncol. 2003. PMID: 12960519 Review.

9

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Kaplan LD, et al. Among authors: sparano ja. Blood. 2005 Sep 1;106(5):1538-43. doi: 10.1182/blood-2005-04-1437. Epub 2005 May 24. Blood. 2005. PMID: 15914552 Free PMC article. Clinical Trial.

10

HIV-associated lymphoma: the evidence for treating aggressively but with caution.

Sparano JA. Sparano JA. Curr Opin Oncol. 2007 Sep;19(5):458-63. doi: 10.1097/CCO.0b013e3282c8c835. Curr Opin Oncol. 2007. PMID: 17762571 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page